Medicine and Dentistry
Patient
100%
Analysis
52%
Diagnosis
47%
Neoplasm
40%
Gene
38%
Therapeutic Procedure
36%
Multiple Myeloma
26%
B Cell
23%
Inpatient
21%
Combination Therapy
20%
Fluorescence in Situ Hybridization
20%
Malignant Neoplasm
20%
DNA
19%
Diseases
18%
B-Cell Chronic Lymphocytic Leukemia
17%
Cells
17%
Rectum Cancer
16%
Overall Survival
15%
Reverse Transcription Polymerase Chain Reaction
15%
Next Generation Sequencing
15%
Specimen
14%
Survival
14%
Paraffin
14%
Formaldehyde
13%
Epidermal Growth Factor Receptor
13%
Tissues
13%
Non Small Cell Lung Cancer
13%
Cetuximab
13%
Progression Free Survival
12%
Assessment
12%
Biological Marker
12%
Oxaliplatin
12%
Sarcoma
12%
Capecitabine
11%
Molecular Diagnosis
11%
Development
11%
Biopsy
10%
Circulating Tumor DNA
10%
Laboratory
10%
Association
9%
Assay
9%
Clinical Trial
9%
Immunoglobulin
9%
Nodular Melanoma
9%
Chemoradiotherapy
8%
Minimal Residual Disease
8%
Adenocarcinoma
8%
Clonal Variation
8%
Evaluation Study
8%
Arm
8%
Biochemistry, Genetics and Molecular Biology
Mutation
82%
Nested Gene
43%
Sample
41%
DNA
34%
Next Generation Sequencing
26%
Immunoglobulin
26%
B Cell
24%
KRAS
23%
Fluorescence in Situ Hybridization
20%
Clonality
17%
Clonal Variation
17%
Circulating Tumor DNA
16%
Overall Survival
15%
Gene Rearrangement
15%
T Cell Receptor
14%
Development
13%
Survival
13%
Reverse Transcription Polymerase Chain Reaction
11%
Polymerase Chain Reaction
11%
Cetuximab
11%
Single-Nucleotide Polymorphism
11%
Polymerase Chain Reaction
10%
Sequencing
9%
Somatic Hypermutation
9%
Plasma Cell
9%
Progression Free Survival
9%
Genetics
9%
Exon
8%
Allele
8%
Genotyping
8%
Bioinformatics
8%
Capecitabine
8%
Cytogenetics
8%
Immunoglobulin Gene
7%
Quality Control
7%
Loss of Heterozygosity
7%
IGHV@
6%
Time
6%
Gene Mutation
6%
Consensus
6%
Immunogenetics
6%
Real-Time Polymerase Chain Reaction
6%
Solid
6%
Immunoglobulin Heavy Chain Gene
6%
Somatic Mutation
5%
Real-Time Polymerase Chain Reaction
5%
Heavy Chain
5%
Mutant
5%
Epidermal Growth Factor Receptor
5%
Germ Cell
5%